Giullia Coradetti, MD, offered insight into her research on a post-hoc analysis based on the GATHER 2 clinical trial data for ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

In addition to the presentations, Viral Kansara, PhD, Vice President, Preclinical Development moderated an ARVO session entitled "Retina/RPE: New drugs, mechanisms of action, and toxicity” and Dr.

In comparison, PM is defined as structural changes in the eye due to excessive elongation of AL, resulting in severe visual impairment and complications such as posterior scleral staphyloma, lacquer ...